{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T17:24:04Z","timestamp":1782581044719,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303309"],"award-info":[{"award-number":["82303309"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118434","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:29:04Z","timestamp":1764779344000},"page":"118434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Chemical induction of ferroptosis through GPX4 inhibition: Rational design of triazole-benzoxazine hybrids for melanoma therapy"],"prefix":"10.1016","volume":"303","author":[{"given":"Bingbing","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhou","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1581-1168","authenticated-orcid":false,"given":"Shuxiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118434_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2024.09.035","article-title":"Global trends in melanoma burden: a comprehensive analysis from the global burden of disease study, 1990-2021","volume":"92","author":"Sun","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejmech.2025.118434_bib2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.118434_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104276","article-title":"The treatment of advanced melanoma: current approaches and new challenges","volume":"196","author":"Boutros","year":"2024","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.ejmech.2025.118434_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.21.02229","article-title":"Long-term outcomes with Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma","volume":"40","author":"Wolchok","year":"2022","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ejmech.2025.118434_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104193","article-title":"Preoperative therapy in melanoma: evolving perspectives in clinical trials","volume":"193","author":"Kakish","year":"2024","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.ejmech.2025.118434_bib6","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1039\/D4RA07540D","article-title":"Discovery of new benzothiazole-1,2,3-triazole hybrid-based hydrazone\/thiosemicarbazone derivatives as potent EGFR inhibitors with cytotoxicity against cancer","volume":"15","author":"Aljuhani","year":"2025","journal-title":"RSC advances"},{"key":"10.1016\/j.ejmech.2025.118434_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2006.03.013","article-title":"Dihydroxy-7-methoxy-1,4-benzoxazin-3-one (DIMBOA) and 2,4-dihydroxy-1,4-benzoxazin-3-one (DIBOA), two naturally occurring benzoxazinones contained in sprouts of gramineae are potent aneugens in human-derived liver cells (HepG2)","volume":"246","author":"Buchmann","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2025.118434_bib8","first-page":"133188","author":"Benarjee","year":"2022","journal-title":"Synthesis of Some New 1, 4-benzoxazine-pyrazoles in Water as EGFR Targeting Anticancer Agents"},{"key":"10.1016\/j.ejmech.2025.118434_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800024","article-title":"Synthesis and biological evaluation of potential acetylcholinesterase inhibitors based on a benzoxazine core","volume":"351","author":"M\u00e9ndez-Rojas","year":"2018","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2025.118434_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejmech.2017.03.034","article-title":"Using gene expression database to uncover biology functions of 1,4-disubstituted 1,2,3-triazole analogues synthesized via a copper (I)-catalyzed reaction","volume":"132","author":"Su","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118434_bib11","article-title":"Design, synthesis, and anti-inflammatory activity of 2H-1,4-benzoxazin-3(4H)-one derivatives modified with 1,2,3-triazole in LPS-Induced BV-2 cells","volume":"15","author":"Hou","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118434_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010230","article-title":"Recent advances in bioactive flavonoid hybrids linked by 1,2,3-Triazole ring obtained by click chemistry","volume":"27","author":"Pereira","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118434_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.579024","article-title":"Discovery of Icotinib-1,2,3-Triazole derivatives as IDO1 inhibitors","volume":"11","author":"Mao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118434_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13065-024-01205-3","article-title":"Synthesis and antitumor activity of dolutegravir derivatives bearing 1,2,3-triazole moieties","volume":"18","author":"Hou","year":"2024","journal-title":"BMC chemistry"},{"key":"10.1016\/j.ejmech.2025.118434_bib15","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1039\/D4RA07294D","article-title":"Design and development of an isatin-1,2,3-triazole hybrid analogue as a potent anti-inflammatory agent with enhanced efficacy and gene expression modulation","volume":"15","author":"Niranjana Kumar","year":"2025","journal-title":"RSC advances"},{"key":"10.1016\/j.ejmech.2025.118434_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400731","article-title":"Synthesis of 1,2,3-Triazole-Methyl-Menadione derivatives: evaluation of electrochemical and antiparasitic properties against two blood-dwelling parasites","volume":"20","author":"Dupouy","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118434_bib17","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1158\/0008-5472.CAN-21-0772","article-title":"AP-2\u03b1-Mediated activation of E2F and EZH2 drives melanoma metastasis","volume":"81","author":"White","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118434_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semcancer.2019.08.024","article-title":"The adjuvant treatment revolution for high-risk melanoma patients","volume":"59","author":"Spagnolo","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2025.118434_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118434_bib20","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1073\/pnas.1332764100","article-title":"A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells","volume":"100","author":"Li","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2025.118434_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening Horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118434_bib22","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/ijc.33479","article-title":"Skin melanoma deaths within 1 or 3 years from diagnosis in Europe","volume":"148","author":"Sacchetto","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.118434_bib23","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA: a cancer journal for clinicians"},{"key":"10.1016\/j.ejmech.2025.118434_bib24","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2147\/IJN.S503753","article-title":"Magnetic microbubbles combined with ICG-loaded liposomes for synergistic mild-photothermal and ferroptosis-enhanced photodynamic therapy of melanoma","volume":"20","author":"Xiong","year":"2025","journal-title":"International journal of nanomedicine"},{"key":"10.1016\/j.ejmech.2025.118434_bib25","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s11101-016-9481-1","article-title":"Plant defense and herbivore counter-defense: benzoxazinoids and insect herbivores","volume":"15","author":"Wouters","year":"2016","journal-title":"Phytochem. Rev. : Proc. Phytochem. Soc. Eur."},{"key":"10.1016\/j.ejmech.2025.118434_bib26","first-page":"393","article-title":"Synthesis and antifungal activity of 2H-1,4-benzoxazin-3(4H)-one derivatives, journal of environmental science and health. Part. B, pesticides","volume":"51","author":"\u015amist","year":"2016","journal-title":"food contaminants, and agricultural wastes"},{"key":"10.1016\/j.ejmech.2025.118434_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1527-3458.2007.00012.x","article-title":"Characterization of the potent 5-HT(1A\/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant\/anxiolytic efficacy","volume":"13","author":"Watson","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejmech.2025.118434_bib28","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1016\/j.bmc.2014.07.038","article-title":"Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists","volume":"22","author":"Hasui","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118434_bib29","doi-asserted-by":"crossref","first-page":"36945","DOI":"10.1021\/acsomega.2c04883","article-title":"Versatile synthetic platform for 1,2,3-Triazole chemistry","volume":"7","author":"Vala","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118434_bib30","article-title":"The current landscape of 1,2,3-triazole-(fused) six-membered nitrogen-containing heteroaromatic ring hybrids with anticancer therapeutic potential","volume":"358","author":"Xu","year":"2025","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2025.118434_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100158","article-title":"1,2,3-Triazole hybrids as anticancer agents: a review","volume":"355","author":"Alam","year":"2022","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2025.118434_bib32","first-page":"273","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism","volume":"171","author":"Stockwell","year":"2017","journal-title":"Redox Biology, and Disease, Cell"},{"key":"10.1016\/j.ejmech.2025.118434_bib33","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2025.118434_bib34","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","article-title":"Targeting ferroptosis opens new avenues for the development of novel therapeutics","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118434_bib35","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Molecular cell"},{"key":"10.1016\/j.ejmech.2025.118434_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11122444","article-title":"SLC7A11 as a gateway of metabolic perturbation and ferroptosis vulnerability in cancer","volume":"11","author":"Lee","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2025.118434_bib37","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.118434_bib38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1107\/S2059798320016125","article-title":"Crystal structures of the selenoprotein glutathione peroxidase 4 in its Apo form and in complex with the covalently bound inhibitor ML162","volume":"77","author":"Moosmayer","year":"2021","journal-title":"Acta crystallographica. Section D, Structural biology"},{"key":"10.1016\/j.ejmech.2025.118434_bib39","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1021\/ci049794h","article-title":"Personal experience with four kinds of chemical structure drawing software: review on ChemDraw, ChemWindow, ISIS\/Draw, and ChemSketch","volume":"44","author":"Li","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2025.118434_bib40","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:45:58Z","timestamp":1781325958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"alternative-id":["S0223523425011997"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118434","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical induction of ferroptosis through GPX4 inhibition: Rational design of triazole-benzoxazine hybrids for melanoma therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118434"}}